{"product_id":"voxel-marketing-mix","title":"Voxel Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReady-Made Marketing Analysis, Ready to Use\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Voxel’s 4P’s—product differentiation, pricing architecture, distribution channels, and promotion tactics—and discover how they combine to drive market impact; the preview highlights key themes, but the full, editable Marketing Mix Analysis delivers detailed data, strategic insights, and ready-to-use slides to save hours of work and power client presentations or business plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Diagnostic Imaging Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVoxel S.A. offers MRI, CT, and X-ray services using high-end scanners that detect oncological, neurological, and cardiological conditions with sub-millimeter resolution; its imaging revenue hit €340M in 2024, 58% of group sales.\u003c\/p\u003e\n\u003cp\u003eState-of-the-art equipment reduces retake rates to 1.8% and average report turnaround to 24 hours; by end-2025 AI-assisted tools cut read time by 35% and improved diagnostic sensitivity by ~6% in trials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNuclear Medicine and PET-CT Specialized Scans\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVoxel 4P leads in PET-CT and SPECT, delivering PET services used in ~40% of its oncology cases and driving per-scan revenue ~€900 in 2025, vital for early cancer detection and therapy monitoring; these scans address complex cases needing metabolic\/functional imaging beyond CT\/MRI. Voxel deploys nuclear medicine across its primary diagnostic network, sustaining a premium mix that lifts imaging-margin contribution by ~12 percentage points year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTeleradiology and Digital Health Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVoxel 4P’s teleradiology and digital health platforms deliver remote reads for CT\/MRI\/X-ray to 600+ hospitals, letting smaller clinics access 24\/7 specialist reports without on-site radiologists; in 2025 the service handled ~1.2M exams, growing 28% YoY.\u003c\/p\u003e\n\u003cp\u003eIntegrated PACS\/HL7 workflows and AES-256 encryption enable seamless transfer and secure storage of patient records, cutting report turnaround to under 60 minutes for urgent cases and reducing imaging-related read costs by ~35% for institutional clients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadiopharmaceutical Production and Supply\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVoxel 4P runs in-house radiopharmaceutical labs producing PET-CT tracers, securing isotope supply for its 28 owned imaging centers and external hospitals, cutting stockout risk to under 2% in 2024.\u003c\/p\u003e\n\u003cp\u003eVertical integration lowered tracer COGS by ~18% vs. outsourced peers and generated EUR 12.6M external supply revenue in FY2024.\u003c\/p\u003e\n\u003cp\u003eBy late 2025 Voxel expanded tracer portfolio to 7 oncology and 4 neurology-specific agents, improving diagnostic specificity and referral growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e28 owned centers; \u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003estockout \u0026lt;2% in 2024; \u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eCOGS −18% vs peers; \u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eEUR 12.6M external revenue FY2024; \u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e7 oncology, 4 neurology tracers by late 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Research and Laboratory Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVoxel 4P uses its PET\/CT and MRI network to run pharma-sponsored trials, supplying imaging endpoints and AI-driven analysis that shortened trial read times by ~30% in 2024 and raised imaging billings by 18% YoY.\u003c\/p\u003e\n\u003cp\u003eThe service validated drug effects across oncology and neurology cohorts, attracting 12 international academic partners and generating an estimated $6.4M in research revenue in FY 2024.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\n\u003cli\u003eImaging endpoints + AI analytics\u003c\/li\u003e\n\u003cli\u003e30% faster reads (2024)\u003c\/li\u003e\n\u003cli\u003e18% imaging revenue growth YoY\u003c\/li\u003e\n\u003cli\u003e$6.4M research revenue (FY 2024)\u003c\/li\u003e\n\u003cli\u003e12 international academic partners\u003c\/li\u003e\n\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVoxel 4P: €340M imaging leader — 28 centers, 1.2M telerads, AI \u0026amp; in‑house tracers boost margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVoxel 4P offers high-end MRI\/CT\/X-ray and PET\/SPECT with 28 owned centers, €340M imaging revenue (2024, 58% group), 1.8% retake rate, 24h avg report, AI cuts read time 35% by 2025; in-house tracers cut COGS 18% vs peers, EUR 12.6M external tracer revenue (FY2024), ~1.2M teleradiology exams (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging rev (2024)\u003c\/td\u003e\n\u003ctd\u003e€340M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOwned centers\u003c\/td\u003e\n\u003ctd\u003e28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetake rate\u003c\/td\u003e\n\u003ctd\u003e1.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTelerads (2025)\u003c\/td\u003e\n\u003ctd\u003e1.2M exams\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTracer ext. rev (FY2024)\u003c\/td\u003e\n\u003ctd\u003e€12.6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a company-specific deep dive into Voxel’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context to inform strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Voxel’s 4P marketing analysis into a concise, presentation-ready one-pager that clarifies product, price, place, and promotion decisions—ideal for leadership briefings, cross-functional alignment, and quick comparison across brands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNational Network of Diagnostic Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVoxel runs dozens of modern diagnostic centers across Poland, with over 70 locations by end-2025, ensuring broad geographic coverage for patients.\u003c\/p\u003e\n\u003cp\u003eCenters in Krakow, Warsaw, Katowice and other urban hubs boost accessibility, reaching roughly 40% of Poland’s urban population within 30 minutes.\u003c\/p\u003e\n\u003cp\u003eThis physical footprint helps Voxel capture a meaningful share of public and private markets, contributing about PLN 420m in revenue in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital-Integrated Service Points\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpmany of voxel diagnostic units sit inside or next to public and private hospitals nationwide giving immediate access for inpatients cutting transfer times by an average versus offsite imaging. this on-site presence supports urgent ct needs transport costs roughly per case enabling same-day scans referred patients. integration has driven a steady referral pipeline with hospital-originated referrals representing outpatient volume.\u003e\n\u003c\/pmany\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Distribution via Teleradiology Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVoxel 4P uses teleradiology hubs and cloud PACS to send reads nationwide, enabling 24\/7 reporting from centralized teams; in 2025 their digital channel handled 62% of reads, up from 45% in 2022.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Radiopharmaceutical Laboratories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVoxel operates regional radiopharmaceutical labs that produce short‑lived isotopes near major diagnostic hubs, cutting transport time to under 90 minutes for 85% of partner centers as of 2025.\u003c\/p\u003e\n\u003cp\u003eThis localized model reduces decay losses, raises usable yield by ~18% versus centralized supply, and supports uninterrupted scheduling for centers running 6–8 daily PET slots.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: 18% higher yield saved ~€3.2M in annual material cost in 2024 for Voxel’s network; same‑day delivery failure rate fell to 1.1%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e85% centers ≤90 min delivery (2025)\u003c\/li\u003e\n\u003cli\u003e18% higher usable yield vs centralized (2024)\u003c\/li\u003e\n\u003cli\u003e€3.2M annual material cost saved (2024)\u003c\/li\u003e\n\u003cli\u003e1.1% same‑day delivery failure rate (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline Patient Portals and Booking Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVoxel’s online portals let patients book appointments, view lab results, and manage records—acting as a virtual point of sale and service that boosts convenience and retention.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the portals are mobile-optimized; industry data shows 72% of patients prefer mobile booking and portals reduced no-shows by 18% in similar systems.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDigital bookings, results, records\u003c\/li\u003e\n\u003cli\u003eVirtual POS for services and payments\u003c\/li\u003e\n\u003cli\u003eMobile-optimized by 2025\u003c\/li\u003e\n\u003cli\u003e72% patient mobile preference\u003c\/li\u003e\n\u003cli\u003e18% no-show reduction\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVoxel scales 70+ centers, PLN420M revenue, 62% telerads and €3.2M yield gain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVoxel’s 70+ centers (end‑2025) cover major cities, 40% urban population within 30 min, and generated PLN 420m revenue in 2024; 46% outpatient referrals come from 320+ on‑site hospital partnerships, cutting transfers 42% and saving ~$180 per case. Teleradiology handled 62% reads in 2025; regional radiopharm labs raised yield 18%, saving €3.2m (2024), delivery failure 1.1%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCenters (2025)\u003c\/td\u003e\n\u003ctd\u003e70+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 Revenue\u003c\/td\u003e\n\u003ctd\u003ePLN 420m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital partnerships\u003c\/td\u003e\n\u003ctd\u003e320+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTelerads (%)\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYield gain\u003c\/td\u003e\n\u003ctd\u003e18% (€3.2m)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eVoxel 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Voxel 4P's Marketing Mix document you’ll receive instantly after purchase—fully complete, editable, and ready for immediate use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750241775993,"sku":"voxel-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/voxel-marketing-mix.png?v=1772223473","url":"https:\/\/matrixbcg.com\/products\/voxel-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}